Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. [electronic resource]
Producer: 20170306Description: 2763-2777 p. digitalISSN:- 1432-0738
- Anthracyclines -- adverse effects
- Antibiotics, Antineoplastic -- adverse effects
- Biomarkers, Pharmacological -- metabolism
- Cardiotoxins -- adverse effects
- Cells, Cultured
- Computational Biology
- Daunorubicin -- adverse effects
- Doxorubicin -- adverse effects
- Drug Evaluation, Preclinical
- Drugs, Investigational -- adverse effects
- Gene Expression Profiling
- Gene Expression Regulation -- drug effects
- Humans
- Induced Pluripotent Stem Cells -- cytology
- Mitoxantrone -- adverse effects
- Molecular Sequence Annotation
- Myocytes, Cardiac -- cytology
- Oligonucleotide Array Sequence Analysis
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Topoisomerase II Inhibitors -- adverse effects
- Toxicity Tests, Chronic
No physical items for this record
Publication Type: Journal Article; Validation Study
There are no comments on this title.
Log in to your account to post a comment.